• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » FDA clears new MR scanner from Siemens Healthineers

FDA clears new MR scanner from Siemens Healthineers

January 4, 2024 By Sean Whooley

Siemens Healthineers MAGNETOM Cima.X product image
The Magnetom Cima.X 3 Tesla (3T) magnetic resonance imaging whole-body scanner. [Image courtesy of Siemens Healthineers]
Siemens Healthineers announced today that the FDA cleared its Magnetom Cima.X 3 Tesla (3T) magnetic resonance imaging whole-body scanner.

Magnetom Cima.X includes the strongest-ever gradients system for a clinically released whole-body MR scanner, according to a news release. This makes smaller structures in the body visible and captures images faster than previous MR scanners. Other design features enhance scientific research and overcome key imaging challenges to visualize cancer and other diseases.

Siemens Healthineers designed its Gemini Gradients for the scanner to register 2.5 times higher than its previous strongest MR gradients in terms of amplitude. They have an amplitude of 200 mT/m and a slew rate of 200 T/m/s. This enables clinicians to better study neurodegenerative diseases, increasing the visibility of microstructures. Users can leverage the same level of gradient across the body, too.

Other new features include Physiologging for precise, time-stamped physiological data from the patient. Magnetom Cima.X’s new Open Recon platform allows clinicians to run custom algorithms for image reconstructions directly on the scanner.

Siemens Healthineers also incorporated features found on previous MR scanners within its portfolio. Its BioMatrix technology automatically adjusts for user variability, plus anatomical and physiological differences of patients. Deep Resolve reconstruction technology, powered by AI, accelerates MR scans by up to 70%. Siemens Healthineers’ myExam Companion workflow incorporates AI to help the radiologic technologist navigate the exam.

“With the FDA clearance of the MAGNETOM Cima.X, Siemens Healthineers proudly offers the scientific and medical communities a whole-body 3T MR scanner that can deliver penetrating new insights into oncologic, cardiac, and neurodegenerative disease,” said Katie Grant, VP of MR at Siemens Healthineers North America.

Filed Under: 510(k), Food & Drug Administration (FDA), Health Technology, Imaging, Regulatory/Compliance, Software / IT Tagged With: FDA, Siemens Healthineers

More recent news

  • Medtronic Diabetes names CFO with consumer experience ahead of separation
  • Preceptis Medical has a new CEO as it advances ear tube tech
  • FDA clears first over-the-counter cuffless blood pressure monitor
  • Mendaera wins FDA clearance for robotic needle placement
  • Johnson & Johnson seeks to have $442 million antitrust verdict tossed out

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy